tiprankstipranks
Trending News
More News >
Piramal Pharma Limited (IN:PPLPHARMA)
:PPLPHARMA
India Market

Piramal Pharma Limited (PPLPHARMA) Income Statement

Compare
10 Followers

Piramal Pharma Limited Income Statement

Last quarter (Q1 2026), Piramal Pharma Limited's total revenue was ₹19.34B, a decrease of -0.89% from the same quarter last year. In Q1, Piramal Pharma Limited's net income was ₹-817.00M. See Piramal Pharma Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₹ 91.51B₹ 81.71B₹ 70.82B₹ 65.59B₹ 58.87B
Gross Profit
₹ 59.20B₹ 49.09B₹ 10.98B₹ 13.80B₹ 38.13B
Operating Expenses
₹ 23.07B₹ 23.04B₹ 11.34B₹ 10.07B₹ 15.68B
Depreciation and Amortization
₹ 7.76B₹ 7.41B₹ 6.77B₹ 5.86B₹ 4.14B
EBITDA
₹ 14.04B₹ 13.67B₹ 8.46B₹ 12.60B₹ 12.97B
Operating Income
₹ 36.12B₹ 5.20B₹ -359.80M₹ 3.74B₹ 22.46B
Other Income/Expenses
₹ -31.97B₹ -3.40B₹ -841.70M₹ 1.11B₹ -13.69B
Pretax Income
₹ 4.15B₹ 1.79B₹ -1.20B₹ 4.85B₹ 8.76B
Net Income
₹ 911.30M₹ 178.20M₹ -1.86B₹ 3.76B₹ 5.71B
Per Share Metrics
Basic EPS
₹ 0.69₹ 0.14₹ -1.54₹ 3.11₹ 4.70
Diluted EPS
₹ 0.68₹ 0.14₹ -1.54₹ 3.11₹ 4.70
Weighted Average Shares Outstanding
1.34B 1.27B 1.21B 1.22B 1.22B
Weighted Average Shares Outstanding (Diluted)
1.34B 1.28B 1.21B 1.22B 1.22B
Currency in INR

Piramal Pharma Limited Earnings and Revenue History